What is the prevalence of myasthenia gravis in the United States?
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901313542946816 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The prevalence of Myasthenia Gravis in the United States is estimated to range from 20 to 475 cases per million, with a typical rate of approximately 173.3 cases per million. Prevalence has shown an increasing trend in recent years. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18394436 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the prevalence of myasthenia gravis in the United States? Tripdatabase myasthenia gravis prevalence United States neurology autoimmune disorder The prevalence of Myasthenia Gravis in the United States is estimated to range from 20 to 475 cases per million, with a typical rate of approximately 173.3 cases per million. Prevalence has shown an increasing trend in recent years. |
| title | What is the prevalence of myasthenia gravis in the United States? |
| topic | myasthenia gravis prevalence United States neurology autoimmune disorder |
| url | https://doi.org/10.5281/zenodo.18394436 |